What You Should Know
- Amazon One Medical has expanded its weight management and GLP-1 clinical care infrastructure across 48 states and Washington, D.C., updating its national delivery framework on September 15, 2026.
- Introduces a bifurcated access model dividing clinical touchpoints into two pathways:
- Insurance-Covered Primary Care Integration: In-person and scheduled video visits embedded within longitudinal primary care across markets with physical One Medical clinics, managing cardiometabolic and diabetes comorbidities under standard insurance plans.
- Cash-Pay On-Demand Virtual Care: 24/7 direct-to-consumer access starting at $39 for asynchronous messaging (where permitted by state regulations) and $59 for on-demand video visits, bypassing annual One Medical membership requirements.
- Integrates directly into Amazon Pharmacy fulfillment rails to surface real-time, upfront medication pricing before appointment booking, offering automatic coupon application that has yielded over $400 million in cumulative consumer savings.
Two Distinct Care Pathways: Integrated Primary Care vs. On-Demand Cash-Pay
To balance comprehensive cardiometabolic disease management with low-friction consumer access, One Medical offers two distinct operational models without requiring an annual One Medical membership to start:
- 1. Comprehensive Primary Care Integration (In-Person & Virtual):
- Clinical Model: Treats obesity as a chronic condition embedded into the patient’s primary care relationship, proactively monitoring intersecting risks such as hypertension, type 2 diabetes, and cardiovascular health.
- Reimbursement: Billed through standard commercial health insurance (subject to regular copays and deductibles).
- Availability: Offered across markets with physical One Medical offices, featuring standardized clinical documentation, protocolized lab reviews, and full prior authorization support.
- 2. On-Demand Cash-Pay Virtual Care (Nationwide Across 48 States & D.C.):
- Clinical Model: A standalone, episodic evaluation pathway for patients seeking direct GLP-1 assessment and prescription management without enrolling in long-term primary care.
- Transparent Visit Pricing: Flat fee of $39 for direct message consultations (where state regulations permit) or $59 for video visits.
- Intake & Follow-Up: Patients complete a digital health intake and upload recent laboratory panels; licensed clinicians evaluate appropriateness and prescribe during the interaction if clinically indicated. Patients receive a 14-day follow-up messaging window post-visit for dose titrations or side-effect questions (medication costs are billed separately and exclude prior authorization navigation).
Amazon Pharmacy Fulfillment & Transparent Drug Pricing
The clinical workflows connect natively with Amazon Pharmacy, providing side-by-side cost comparisons, automated manufacturer coupons (surpassing $400 million in customer savings to date), and physical distribution:
- Oral GLP-1 Formulations: Stocks oral options including Wegovy and Foundayo oral pills, starting at $25 per month with eligible insurance or $149 per month cash-pay.
- Injectable Formulations: Offers Wegovy, Zepbound auto-injectors, and KwikPen multi-dose devices with cash-pay pricing starting at $199 per month.
- Distribution Infrastructure: Prescriptions are delivered nationwide with same-day home delivery active in roughly 3,100 cities and towns (scaling toward nearly 4,500 by year-end 2026), alongside physical pickup lockers inside select One Medical clinic kiosks.
Strategic Rationale: Full-Stack Healthcare Distribution
The nationwide expansion signals Amazon’s playbook for scaling digital health: pairing asynchronous and synchronous telehealth front doors with automated pharmacy distribution. By offering a cash-pay tier starting at $39, Amazon positions One Medical as a direct competitor to direct-to-consumer digital health providers like Ro, Hims & Hers, and Noom, while preserving clinical continuity by leveraging its physical primary care clinics and in-network insurance contracts for higher-acuity, multi-condition patients.
